Abbott Vascular

Santa Clara, California 95054

0 studies enrolling now · 15 studies all time

What they study most

Amaurosis Fugax, Angioplasty, Cardiovascular Disease, Carotid Artery Disease, Chronic Coronary Occlusion, Chronic Total Occlusion (CTO), Coronary Artery Disease, Coronary Artery Disease (CAD), Coronary Artery Stenosis, Coronary Disease, Coronary Heart Disease, Coronary Restenosis

Studies at this site

• XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study — Completed
• EXCEL Clinical Trial — Completed
• A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT) — Completed
• XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study — Completed
• EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions — Completed
• Absolute Pro® MOMENTUM™ — Completed
• Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy — Completed
• Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery — Completed
• XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort) — Completed
• Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery. — Completed
• CHOICE: Carotid Stenting For High Surgical-Risk Patients — Completed
• The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis — Completed
• CAPTURE 2 Post-Marketing Registry — Completed
• EXCEL Clinical Trial (Universal Registry) — Completed
• XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1) — Completed